US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist
  • 0.699
  • -0.025-3.40%
Trading Dec 3 13:04 ET
178.76MMarket Cap-4183P/E (TTM)

About Adaptimmune Therapeutics Company

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.

Company Profile

SymbolADAP
Company NameAdaptimmune Therapeutics
Listing DateMay 6, 2015
Issue Price17.00
Founded2008
CEOMr. Adrian Rawcliffe
MarketNASDAQ
Employees449
Securities TypeDR
ADS Ratio1.0 : 6.0
Fiscal Year Ends12-31
Address60 Jubilee Avenue,Milton Park
CityAbingdon
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX14 4RX
Phone44-1235-430000

Company Executives

  • Name
  • Position
  • Salary
  • Adrian Rawcliffe
  • Director and Chief Executive Officer
  • 2.77M
  • James J. Noble
  • Chief Executive Officer and Director
  • --
  • John Lunger
  • Chief Patient Supply Officer
  • --
  • Gavin Hilary James Wood
  • Chief Financial Officer and Principal Accounting Officer
  • 1.17M
  • Dr. Elliot Norry
  • Chief Medical Officer
  • 1.18M
  • Cintia Piccina
  • Chief Commercial Officer
  • --
  • William C. Bertrand, Jr
  • Chief Operating Officer
  • 1.22M
  • Dr. Helen Tayton-Martin, PhD
  • Chief Business and Strategy Officer
  • 1.18M
  • Dr. Joanna Brewer
  • Chief Scientific Officer
  • --
  • David M. Mott
  • Chairman of the Board
  • 174.83K
  • Dr. Andrew R. Allen, M.D.,PhD
  • Independent Director
  • 83.50K
  • Dr. Priti Hegde, PhD
  • Independent Director
  • 82.25K
  • Dr. Kristen M. Hege, M.D.
  • Independent Director
  • 72.63K
  • Dr. Ali Behbahani, M.B.A.,M.D.
  • Independent Director
  • 111.54K
  • Lawrence M. Alleva
  • Independent Director
  • 128.80K
  • John P. Furey
  • Independent Director
  • 117.25K
  • Dr. Garry E. Menzel, PhD
  • Independent Director
  • 117.29K
Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data